Univariate Multivariate | |||||
---|---|---|---|---|---|
Variables | HR (95%CI) | P value | HR (95%CI) | P value | |
Age (≥ 48 vs. < 48) | 1.18 (0.48–2.90) | 0.684 | |||
Cycles of chemotherapy (≥ 3 vs. < 3) | 1.47 (1.06–2.17) | 0.041 | 1.34(0.65–3.27) | 0.341 | |
Tumor size (≥ 4.85 vs. < 4.85) | 0.65 (0.23–1.74) | 0.403 | |||
Tumor differentiation (moderately/well vs. poor) | 2.26 (1.03–5.03) | 0.008 | 2.07 (1.11–4.01) | 0.022 | |
Clinical TNM stage (III vs. II) | 0.44 (0.22–0.91) | 0.013 | 0.28 (0.09–0.81) | 0.029 | |
AFR (< 10.85 vs. ≥ 10.85) | 0.18 (0.05–0.53) | 0.002 | 0.36 (0.15–0.73) | 0.011 | |
CEA (≥ 5.0 vs. < 5.0) | 1.24 (0.45–3.43) | 0.652 | |||
CA19–9 (≥ 40 vs. < 40) | 1.14 (0.48–2.81) | 0.776 |